CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-28 | Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS | Grant or award | +4,854 | $2.96 | $14K | 16,509 |
| 2024-06-28 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award | +4,854 | $2.96 | $14K | 10,487 |
| 2024-06-24 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2024-06-24 | Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2024-06-24 | Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2024-06-24 | Prince Joshua S. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2024-03-04 | Rotunno Mary L. Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-03-04 | GIN JERRY B Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-03-04 | FitzPatrick Margaret M Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-03-04 | Curley Joanne Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-03-04 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-03-04 | SAXE JON S Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2023-12-29 | Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS | Grant or award | +167 | $1.72 | $287 | 11,655 |
| 2023-12-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award | +167 | $1.72 | $287 | 5,633 |
| 2023-10-04 | COMMODORE CAPITAL LP 10% owner | Grant or award · Pre-Funded Warrants (Right to Buy) | +2,788,620 | 2,788,620 | ||
| 2023-10-04 | COMMODORE CAPITAL LP 10% owner | Grant or award · Tranche 1 Warrants (Right to Buy) | +1,394,310 | 1,394,310 | ||
| 2023-10-04 | COMMODORE CAPITAL LP 10% owner | Grant or award · Tranche 2 Warrants (Right to Buy) | +1,690,014 | 1,690,014 | ||
| 2023-08-21 | Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +8,333 | 8,333 | ||
| 2023-08-07 | COMMODORE CAPITAL LP 10% owner | Purchase | +775,756 | $23.15 | $18.0M | 1,575,000 |
| 2023-06-30 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award | +167 | $1.59 | $265 | 5,466 |
Page 3 of 17 · 323 trades